Sean Lu

Temasek Holdings (Pte) Ltd. operates as a sovereign wealth fund. It invests in financial services, telecommunications, media, technology, consumer, real estate, transportation, industrials, life sciences, agri business, energy and resources. The firm specializes in growth capital, restructuring and divestiture transactions. The company was founded in 1974 and is headquartered in Singapore.

China Time Share Media Co., Ltd. provided advertising services. The company was founded in 2006 and was headquartered in Beijing, China.

I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.

C-Bridge Capital LLC (C-Bridge Capital) is a venture capital subsidiary of CBC Group founded in 2019 by Fu Wei. The firm is headquartered in New York..

AffaMed Therapeutics is a Chinese company focused on providing innovative treatments to patients. The company is based in Shanghai, CN. The company's mission and vision are centered around improving patient access to these treatments. The company has a pipeline of products in development to achieve this goal. and has subsidiaries in United States and Hong Kong. The CEO of the company is Dayao Zhao.

McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

New Leaf Venture Partners LLC (New Leaf Ventures) is an independent Venture Capital firm founded by Jeani Delagardelle, Philippe Chambon, Vijay Lathi, Ron Hunt, James Niedel, and Kathy LaPorte. The firm is headquartered in New York. It spun out from Sprout Group.

New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.

Part of State of Texas, Texas Permanent School Fund invests for the benefit of public schools. The company is based in Austin, TX. The company was created in 1845 as a perpetual fund to support the state's public schools and has since grown to comprise over $51 billion. The company's Bond Guarantee Program guarantees bonds issued by independent and charter school districts, enhancing their credit rating. The program is designed for school districts with credit ratings lower than AAA. PSF makes biennial distributions into the Available School Fund, a fund established for the support and maintenance of public K-12 and charter schools.

Portola Capital Partners is a private equity firm founded in 1992. The firm is headquartered in Silicon Valley, California.

Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California.

Part of Match Group, Inc., SK Holdings, Inc. is a company based in New York, NY.

Korea Evaluation Institute of Industrial Technology operates as a research institute to develop technology for domestic industries. The company is based in Daegu, South Korea. The South Korean company is ultimately controlled by the Government of South Korea.

InxMed Biotechnology Nanjing Co., Ltd. is a clinical-stage biotech company established in 2018, dedicated to developing innovative therapies to overcome treatment resistance, especially anti PD-1/PD-L1 resistance. InxMed is based in Nanjing, China, and has teams located in Shanghai and Beijing, with hubs in San Francisco and Melbourne. The Chinese company's innovations are inspired by patients and driven by in-depth understanding of disease biology and pharmacology. InxMed has raised tens of millions of US dollars in series A round financing and has an integrated high-caliber research and clinical development team across China, the US, and Australia. The company has built a unique innovative pipeline through its own discovery research and development and collaborative research and development. The company was founded in 2018 by Fei Cao and Zai Qi Wang, with Zai Qi Wang serving as the CEO since then.

M31 Capital Management Ltd (M31 Capital) is a private equity firm founded in 2016 by Lei Zhong. The firm is headquartered in Shanghai, China.

I-Mab Bio-tech (Tianjin) Co., Ltd. engages in the research and development of medicine and biological products. Its business activities include investment information consultation, and health information services. The company was founded on April 19, 2012 and is headquartered in Tianjin, China.

PT Kalbe Genexine Biologics is a clinical-stage biotech company based in Jakarta, Indonesia. The Indonesian company specializes in licensing novel biologics and biosimilars in oncology and high-specialty therapeutic areas, as well as contract manufacturing. The company was founded in 2016 and is backed by Kalbe and Genexine, as well as US private equity giant General. The CEO is Sie Djohan.

Lunia Capital LP is an independent hedge fund management firm headquartered in Dallas, Texas. The firm was founded by Vikas Lunia in 2016. Lunia Capital provides investment advisory services to one or more private investment funds and/or separately managed accounts. Investors in the fund and/or owners of managed accounts may include, but are not limited to, high net worth individuals, family offices, fund-of-hedge funds, endowments, foundations, trusts, charitable organizations, pension plans, and corporate or business entities.

The Bill & Melinda Gates Foundation is a nonprofit organization that aims to help people lead healthy and productive lives. The non-profit company is based in Seattle, WA, and has subsidiaries in the United States. The company's mission is to create a world where everyone has equal opportunities. The company is guided by the belief that every life has equal value. The foundation is currently working on 'the big catch-up' project, which aims to increase vaccination levels among children to pre-pandemic levels and strengthen primary healthcare services for essential immunization in the future. The company was founded by Melinda French Gates and William H. Gates, and the CEO is Mark Suzman.

Wisdoms Auto Parts (Changzhou) Co., Ltd. operates as a holding company that manufactures automobile engines and parts. Its business activities include the manufacturing of general machinery parts, vehicle electrical machinery parts, mould and parts, clamp and its components, as well as the provision of related manufacturing technical consulting services. The company was founded on April 10, 2008 and is headquartered in Changzhou, China.

Fermenstation Co., Ltd. is a company based in Tokyo, Japan that specializes in OEM and ODM of organic cosmetics and sustainable products. The Japanese company caters to the demand for clean beauty, vegan, and organic certified products. The company offers a complete service from proposing raw materials tailored to the customer's needs to developing original products with a story. Fermenstation Co. was founded in 2009 by Hayato Watanabe and Rina Sakai.

Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA.

The Innovation Network Corporation of Japan (INCJ), a unique public-private partnership aimed at promoting innovation and enhancing the value of businesses in Japan, was launched in July 2009. Leveraging the rich history of Japanese technological prowess, the INCJ aims to provide financial, technological and management support in order to promote the creation of next-generation businesses through 'open innovation,' or the flow of technology and expertise beyond the boundaries of existing organizational structures. The INCJ will draw on funding as well as management and technological expertise from the public and private sectors. The INCJ is actively reviewing various investment opportunities in areas of environment and energy, electronics and IT, bio-tech, and infrastructure such as water supply, railway service, and nuclear power supply. Each investment will be thoroughly vetted to ensure it meets the exacting standards of the INCJ's Innovation Network Committee, which will make the final investment decisions. The INCJ is capitalized at 92 billion yen, with the Japanese government injecting 82 billion yen and 19 private corporations (refer to details in Appendix below) providing a further 10 billion yen. The government will also provide guarantees up to a total of 800 billion yen for INCJ investments, giving it an investment capability of approximately 900 billion yen (US$10 billion). The INCJ will be established for a period of 15 years.

Shanghai Fosun High Technology (Group) Co., Ltd. engages in the provision of investment management and consulting services. Its business scopes include financial management, marketing, employee training and management, and technical support services. The company was founded on March 8, 2005 and is headquartered in Shanghai, China.